Interesting point
The main issue is percutaneous administration vs the more complex way that Sirtex administers it - so it can be a commercial threat to Sirtex. Also the OSL patent allows for administration of the same radioisotope as Sirtex uses... as long as it has a bit of P32 thrown in (I havent looked at the patent for a while but that is my recollection as I asked the question to someone who used to work at OSL).
I suspect Sirtex wouldnt be interested but another pharmaceutical company or similar might.
However currently OSL doesnt have a lot of runs on the board and are still quoting a study from almost 10 years ago.
Remember Clinical Cell Culture and why that fell over ?
- Forums
- ASX - By Stock
- Potential
Interesting point The main issue is percutaneous administration...
-
- There are more pages in this discussion • 16 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add OSL (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.5¢ |
Change
0.001(7.14%) |
Mkt cap ! $52.97M |
Open | High | Low | Value | Volume |
1.4¢ | 1.5¢ | 1.4¢ | $96.91K | 6.848M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 1737888 | 1.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.5¢ | 3600037 | 11 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
8 | 1737888 | 0.014 |
18 | 12633035 | 0.013 |
16 | 8786681 | 0.012 |
18 | 8704466 | 0.011 |
17 | 11298020 | 0.010 |
Price($) | Vol. | No. |
---|---|---|
0.015 | 3600037 | 11 |
0.016 | 4392825 | 5 |
0.017 | 5572214 | 4 |
0.018 | 2132208 | 5 |
0.019 | 900000 | 3 |
Last trade - 12.11pm 08/10/2024 (20 minute delay) ? |
Featured News
OSL (ASX) Chart |